MAPK3 and neoplasm: It is likely that SC-1 is reaching at least one of its reported molecular targets (ERK1/2) [12] since as early as 5 min following exposure, the ratio of phospho-ERK1/2 to total ERK1/2 protein levels was decreased in the HT29 tumor line.